ARCHIVES

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

This article is from The Cancer Letter archive.

Vol. 32 No. 31 | September 8, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Human Tissue Network Resources Available For Research

January 24, 1997

How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment

April 13, 2012

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998

Carmona’s Term as Surgeon General Expires.

August 4, 2006

Two-Month Longer Survival Found With Gliadel Wafer

March 31, 2006

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011